EUVIMEDEUVIMED entdecken
Crossref

Development and validation of an IGF-1-modified Child-Pugh score to risk-stratify hepatocellular carcinoma patients

Rania Naguib, Wafaa El-Shikh, Manal Hassan, Hesham Hassabo, Jeong-Hoon Lee, Jung-Hwan Yoon, Hyo-Suk Lee, Jeffrey Morris, JamesL Abbruzzese, YoungKwang Chae, AhmedO Kaseb, Lianchun Xiao

Egyptian Journal of Obesity, Diabetes and Endocrinology · 2015

DOI: 10.4103/2356-8062.159986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Egyptian Journal of Obesity, Diabetes and Endocrinology, 2015. Verfasst von Rania Naguib und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BackgroundThe Child-Turcotte-Pugh (CTP) score inaccurately predicts survival in patients with chronic liver disease, including hepatocellular carcinoma (HCC), yet remains the standard tool for assessing hepatic reserve and guiding therapeutic decisions. CTP scoring relies on objective laboratory values for albumin, bilirubin, and prothrombin time and subjective clinical grading of hepatic encephalopathy and ascites. As liver production of insulin-like growth factor-1 (IGF-1) is significantly reduced in patients with cirrhosis, we hypothesized that IGF-1 could be a valid surrogate for hepatic reserve to replace the subjective parameters in CTP scores.Materials and methodsWe prospectively enrolled patients and collected data and retrospectively tested plasma IGF-1 levels in four independent cohorts: two HCC cohorts from the USA [n = 310 (training set) and n = 99 (validation set 1)]; one HCC cohort from Korea [n = 188 (validation set 2)]; and one cirrhosis cohort from Egypt [n = 71 (validation set 3)]. Recursive partitioning identified within the training set three optimal IGF-1 ranges that correlated with survival: >50 ng/ml = 1 point; 26-50 ng/ml = 2 points; and

Zitieren

APA

Naguib, R., El-Shikh, W., Hassan, M., Hassabo, H., Lee, J., Yoon, J., Lee, H., Morris, J., Abbruzzese, J., Chae, Y., Kaseb, A., & Xiao, L. (2015). Development and validation of an IGF-1-modified Child-Pugh score to risk-stratify hepatocellular carcinoma patients. Egyptian Journal of Obesity, Diabetes and Endocrinology. https://doi.org/10.4103/2356-8062.159986

Vancouver

Naguib R, El-Shikh W, Hassan M, Hassabo H, Lee J, Yoon J, et al. Development and validation of an IGF-1-modified Child-Pugh score to risk-stratify hepatocellular carcinoma patients. Egyptian Journal of Obesity, Diabetes and Endocrinology. 2015. doi:10.4103/2356-8062.159986

BibTeX
@article{Naguib2015,
  author = {Naguib, Rania and El-Shikh, Wafaa and Hassan, Manal and Hassabo, Hesham and Lee, Jeong-Hoon and Yoon, Jung-Hwan and Lee, Hyo-Suk and Morris, Jeffrey and Abbruzzese, JamesL and Chae, YoungKwang and Kaseb, AhmedO and Xiao, Lianchun},
  title = {Development and validation of an IGF-1-modified Child-Pugh score to risk-stratify hepatocellular carcinoma patients},
  journal = {Egyptian Journal of Obesity, Diabetes and Endocrinology},
  year = {2015},
  doi = {10.4103/2356-8062.159986}
}
Kostenlos starten →